Expression patterns of connexin 26 and connexin 43 mRNA in canine benign and malignant mammary tumours

Veterinary Journal

Volumn 172, Issue 1, 2006, Pages 178-180

  Gotoh, Haruka ^a   Harada, Kayono ^a   Suzuki, Kazuyuki ^a   Hashimoto, Shizu ^b   Yamamura, Hozumi ^b   Sato, Tsuneo ^a   Fukumoto, Keiko ^c   Hagiwara, Hiromi ^c   Ishida, Tatsuya ^c   Yamada, Kazuhiko ^c   Asano, Ryuji ^a   Yano, Tomohiro ^c  

^a NIHON UNIVERSITY   (Japan)

^b Kitagawa Animal Hospital   (Japan)

^c NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

Author keywords

Canine; Connexin; Mammary gland tumour; RT PCR

Indexed keywords

CONNEXIN 26; CONNEXIN 43; GAP JUNCTION PROTEIN; MESSENGER RNA;

ANIMAL DISEASE; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; BREAST ADENOMA; BREAST CANCER; BREAST TUMOR; CARCINOGENESIS; CARCINOGENICITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENETIC CODE; MAMMARY GLAND; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION;

ANIMALS; CASE-CONTROL STUDIES; CONNEXIN 43; CONNEXINS; DOG DISEASES; DOGS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; MAMMARY NEOPLASMS, ANIMAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33744909379     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2005.02.023     Document Type: Article

References (14)

1. Brodey R.S., Goldschmidt M.A., and Roszel J.R. Canine mammary gland neoplasms. Journal of American Animal Hospital Associations 19 (1983) 61-90
2. Jamieson S., Going J.J., D'Arcy R., and George W.D. Expression of gap junction proteins connexin 26 and connexin 43 in normal human breast and in breast tumours. Journal of Pathology 84 (1998) 37-43
3. Laird D.W., Fistouris P., Batist G., Alpert L., Huynh H.T., Carystinos G.D., and Alaoui-Jamali M.A. Deficiency of connexin 43 gap junctions is an independent marker for breast tumours. Cancer Research 59 (1999) 4104-4110
4. Lee S.W., Tomasetto C., Paul D., Keymarsi K., and Sager R. Transcriptional downregulation of gap-junction proteins blocks junctional communication in human mammary tumour cell lines. Journal of Cell Biology 118 (1992) 1213-1221
5. Locke D. Gap junctions in normal and neoplastic mammary glands. Journal of Pathology 186 (1998) 343-349
6. Natsuyama S., Nakamura M., Yonezawa K., Shimada T., Ohashi F., Takamori Y., and Kubo K. Expression patterns of the erbB subfamily mRNA in canine benign and malignant mammary tumours. Journal of Veterinary Medical Science 63 (2001) 949-954
7. Mesnil M., and Yamasaki H. Cell-cell communication and growth control of normal and cancer cells: evidence and hypothesis. Molecular Carcinogenesis 7 (1993) 14-17
8. Misdrop W., Cotchin E., Hampe J.F., Jabara A.G., and Von Sanderleben J. Canine malignant mammary tumours. III. Special types of carcinomas, malignant mixed tumours. Veterinary Pathology 10 (1973) 241-256
9. Momiyama M., Omori Y., Ishizuka Y., Nishikawa Y., Tokairin T., Ogawa J., and Enomoto K. Connexin26-mediated gap junctional communication reverses the malignant phenotype of MCF-7 breast cancer cells. Cancer Sciences 95 (2003) 501-507
10. Monaghan P., Clarke C., Persinghe N.P., Moss D.W., Chen X.Y., and Evans W.H. Gap junction distribution and connexin expression in human breast. Experimental Cell Research 223 (1996) 29-38
11. Pozzi A., Risek B., Kiang D.T., Gilula N.B., and Kumar N.M. Analysis of multiple gap junction gene products in the rodent and human mammary gland. Experimental Cell Research 220 (1995) 212-219
12. Tan L.I., Bianco T., and Dobrovic A. Variable promoter region CpG island methylation of the putative tumour suppressor gene connexin 26 in breast cancer. Carcinogenesis 23 (2002) 231-236
13. Yano T., Hernandez-Blazuqueze F., Omori Y., and Yamasaki H. Reduction of malignant phenotype of HepG2 cell is associated with the expression of connexin 26 but not connexin 32. Carcinogenesis 22 (2001) 1593-1600
14. Yano T., Ito F., Satoh H., Hagiwara K., Nakazawa H., Toma H., and Yamasaki H. Tumour-suppressive effect of connexin 32 in renal cell carcinoma from haemodialysis patients. Kidney International 63 (2003) 381